FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033369110> ?p ?o ?g. }

• W3033369110 abstract "Background: The relationship between invasive vascular procedures and bleeding in patients with peripheral artery disease has not been well described in the literature. This post hoc analysis from the EUCLID trial (Examining Use of Ticagrelor in Peripheral Artery Disease) aimed to describe the incidence of major and minor postprocedural bleeding and characterize the timing and severity of bleeding events relative to the procedure. Methods: EUCLID was a multicenter, randomized controlled trial of 13 885 patients with symptomatic peripheral artery disease that tested the efficacy and safety of ticagrelor compared with clopidogrel for the prevention of major adverse cardiovascular events. A total of 2661 patients underwent 3062 coronary revascularization, peripheral revascularization, and amputation during the study. The primary safety end point was Thrombolysis in Myocardial Infarction major or minor bleeding. All bleeding events were formally adjudicated by a clinical end point classification group. Results: Major bleeding events most often occurred ≤7 days following the procedure. The incidence of Thrombolysis in Myocardial Infarction major or minor bleeding ≤7 days following peripheral revascularization (3.3%; 95% CI, 2.5%–4.1%) was similar to rates after coronary revascularization (4.0%; 95% CI, 2.6%–5.4%) and lower extremity amputation (2.3%; 95% CI, 0.8%–3.8%). The severity of bleeding events (as graded by drop in hemoglobin, need for transfusion, bleeding in a critical location, and fatal bleeding) was also similar following peripheral, coronary revascularization, and lower extremity amputation. Conclusions: The incidence of Thrombolysis in Myocardial Infarction major/minor bleeding following peripheral revascularization is comparable to rates after coronary revascularization and lower extremity amputation, and the majority of bleeding events occur within 7 days following the procedure. The severity of periprocedural bleeding is also similar after procedures, with the most frequently adjudicated reason being a drop in hemoglobin ≥2 g/dL. Future studies should be performed to enhance our understanding of bleeding risk related to revascularization and amputation procedures in peripheral artery disease patients." @default.
• W3033369110 created "2020-06-12" @default.
• W3033369110 creator A5005158159 @default.
• W3033369110 creator A5006133112 @default.
• W3033369110 creator A5014777482 @default.
• W3033369110 creator A5015327081 @default.
• W3033369110 creator A5023436952 @default.
• W3033369110 creator A5038722538 @default.
• W3033369110 creator A5039432822 @default.
• W3033369110 creator A5044393078 @default.
• W3033369110 creator A5049378858 @default.
• W3033369110 creator A5053327237 @default.
• W3033369110 creator A5076746946 @default.
• W3033369110 creator A5084489827 @default.
• W3033369110 creator A5088017620 @default.
• W3033369110 date "2019-10-01" @default.
• W3033369110 modified "2023-09-23" @default.
• W3033369110 title "Impact of Procedural Bleeding in Peripheral Artery Disease" @default.
• W3033369110 cites W2037500444 @default.
• W3033369110 cites W2044658006 @default.
• W3033369110 cites W2094831280 @default.
• W3033369110 cites W2100269575 @default.
• W3033369110 cites W2104986306 @default.
• W3033369110 cites W2124859603 @default.
• W3033369110 cites W2125834020 @default.
• W3033369110 cites W2148374679 @default.
• W3033369110 cites W2556414715 @default.
• W3033369110 cites W2589723429 @default.
• W3033369110 cites W2607030557 @default.
• W3033369110 cites W2616996027 @default.
• W3033369110 cites W84710912 @default.
• W3033369110 doi "https://doi.org/10.1161/circinterventions.119.008069" @default.
• W3033369110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31581789" @default.
• W3033369110 hasPublicationYear "2019" @default.
• W3033369110 type Work @default.
• W3033369110 sameAs 3033369110 @default.
• W3033369110 citedByCount "4" @default.
• W3033369110 countsByYear W30333691102021 @default.
• W3033369110 countsByYear W30333691102022 @default.
• W3033369110 countsByYear W30333691102023 @default.
• W3033369110 crossrefType "journal-article" @default.
• W3033369110 hasAuthorship W3033369110A5005158159 @default.
• W3033369110 hasAuthorship W3033369110A5006133112 @default.
• W3033369110 hasAuthorship W3033369110A5014777482 @default.
• W3033369110 hasAuthorship W3033369110A5015327081 @default.
• W3033369110 hasAuthorship W3033369110A5023436952 @default.
• W3033369110 hasAuthorship W3033369110A5038722538 @default.
• W3033369110 hasAuthorship W3033369110A5039432822 @default.
• W3033369110 hasAuthorship W3033369110A5044393078 @default.
• W3033369110 hasAuthorship W3033369110A5049378858 @default.
• W3033369110 hasAuthorship W3033369110A5053327237 @default.
• W3033369110 hasAuthorship W3033369110A5076746946 @default.
• W3033369110 hasAuthorship W3033369110A5084489827 @default.
• W3033369110 hasAuthorship W3033369110A5088017620 @default.
• W3033369110 hasBestOaLocation W30333691101 @default.
• W3033369110 hasConcept C120665830 @default.
• W3033369110 hasConcept C121332964 @default.
• W3033369110 hasConcept C126322002 @default.
• W3033369110 hasConcept C127413603 @default.
• W3033369110 hasConcept C141071460 @default.
• W3033369110 hasConcept C164705383 @default.
• W3033369110 hasConcept C168563851 @default.
• W3033369110 hasConcept C203092338 @default.
• W3033369110 hasConcept C2776204877 @default.
• W3033369110 hasConcept C2777466421 @default.
• W3033369110 hasConcept C2777849778 @default.
• W3033369110 hasConcept C2778213512 @default.
• W3033369110 hasConcept C2779464278 @default.
• W3033369110 hasConcept C2779581417 @default.
• W3033369110 hasConcept C2780645631 @default.
• W3033369110 hasConcept C46762472 @default.
• W3033369110 hasConcept C500558357 @default.
• W3033369110 hasConcept C61511704 @default.
• W3033369110 hasConcept C71924100 @default.
• W3033369110 hasConcept C78519656 @default.
• W3033369110 hasConceptScore W3033369110C120665830 @default.
• W3033369110 hasConceptScore W3033369110C121332964 @default.
• W3033369110 hasConceptScore W3033369110C126322002 @default.
• W3033369110 hasConceptScore W3033369110C127413603 @default.
• W3033369110 hasConceptScore W3033369110C141071460 @default.
• W3033369110 hasConceptScore W3033369110C164705383 @default.
• W3033369110 hasConceptScore W3033369110C168563851 @default.
• W3033369110 hasConceptScore W3033369110C203092338 @default.
• W3033369110 hasConceptScore W3033369110C2776204877 @default.
• W3033369110 hasConceptScore W3033369110C2777466421 @default.
• W3033369110 hasConceptScore W3033369110C2777849778 @default.
• W3033369110 hasConceptScore W3033369110C2778213512 @default.
• W3033369110 hasConceptScore W3033369110C2779464278 @default.
• W3033369110 hasConceptScore W3033369110C2779581417 @default.
• W3033369110 hasConceptScore W3033369110C2780645631 @default.
• W3033369110 hasConceptScore W3033369110C46762472 @default.
• W3033369110 hasConceptScore W3033369110C500558357 @default.
• W3033369110 hasConceptScore W3033369110C61511704 @default.
• W3033369110 hasConceptScore W3033369110C71924100 @default.
• W3033369110 hasConceptScore W3033369110C78519656 @default.
• W3033369110 hasIssue "10" @default.
• W3033369110 hasLocation W30333691101 @default.
• W3033369110 hasLocation W30333691102 @default.
• W3033369110 hasOpenAccess W3033369110 @default.
• W3033369110 hasPrimaryLocation W30333691101 @default.

• next